Full text is available at the source.
Abstract
Fecal calprotectin levels may indicate gut-brain axis dysfunction in Parkinson's disease.
- Elevated fecal calprotectin is associated with intestinal inflammation.
- The study focuses on idiopathic Parkinson's disease and atypical parkinsonian syndromes, including progressive supranuclear palsy and multiple system atrophy.
- There may be a relationship between fecal calprotectin levels and both motor and non-motor features of Parkinson's disease.
- Findings could provide insights into the role of gut inflammation in parkinsonian disorders.
Simplified